List of insiders holdings for Axsome Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Antecip Capital LLC 10% Owner | 2015-12-04 16:52:32 | 7,351,729 0 | 7,351,729 | Form 13D |
| Coleman Mark Director | 2025-01-06 16:06:29 | 57,137 403,856 | 460,993 | Form 4 |
| Golubieski John Chief Financial Officer | 2017-08-08 16:25:42 | 132,000 0 | 132,000 | Form 4 |
| TABUTEAU HERRIOT Chief Executive Officer 10% Owner | 2025-02-25 19:51:26 | 86,105 0 | 86,105 | Form 4 |
| Marek David C Chief Commercial Officer | 2020-03-19 21:19:02 | 70,517 0 | 70,517 | Form 4 |
| Jacobson Mark L. Chief Operating Officer | 2025-02-25 19:53:23 | 32,413 0 | 32,413 | Form 4 |
| Pizzie Nick Chief Financial Officer | 2025-02-25 19:54:49 | 28,362 0 | 28,362 | Form 4 |
| Ames Constance Vice President, Finance | 2017-03-17 17:00:08 | 25,000 0 | 25,000 | Form 4 |
| Murdock Hunter R. General Counsel | 2025-02-25 19:56:12 | 23,296 0 | 23,296 | Form 4 |
| Maizel Ari Chief Commercial Officer | 2025-02-25 19:57:56 | 23,296 0 | 23,296 | Form 4 |
| POTTER MYRTLE S Director | 2019-06-10 18:20:59 | 13,000 0 | 13,000 | Form 4 |
| Kaye Randall Chief Medical Officer | 2015-12-24 13:02:23 | 0 6,022 | 6,022 | Form 4 |
| Saad Mark E Director | 2025-02-25 19:59:08 | 1,494 0 | 1,494 | Form 4 |
| JEFFS ROGER Director | 2025-02-25 20:00:39 | 1,408 0 | 1,408 | Form 4 |
| Mahony Susan Director | 2025-02-25 20:02:19 | 1,312 0 | 1,312 | Form 4 |